Company Description
Arkema SA is engaged in the manufacturing and marketing of vinyl products, industrial chemicals, and performance products. Vinyl products include chlorine or caustic soda, pipes and profiles, PVC, and vinyl compounds. Industrial chemicals include emulsion systems, fluorochemicals, hydrogen peroxide, PMMA and methacrylics, specialty acrylic polymers and thiochemicals. Performance products include functional additives, specialty chemicals and technical polymers. The Company's products can be used for various purposes including air conditioning or refrigeration; chemical processing, coating, construction; packaging; automotive & transportation. Its products, also find their application in adhesives and sealants, agriculture & agrochemicals, consumer goods, electronics, foams, solvents and aerosols market, health, hygiene & beauty, oil & gas, energy, pharmaceuticals, pulp & paper, rubber market, sports & leisure, etc. Arkema SA is headquartered in France.
Financials, Fundamental Metrics & Ratios
| Revenue (Most Recent Fiscal Year) |
$10.33B |
| Net Income (Most Recent Fiscal Year) |
$383.06M |
| PE Ratio (Current Year Earnings Estimate) |
9.99 |
| PE Ratio (Trailing 12 Months) |
8.80 |
| PEG Ratio (Long Term Growth Estimate) |
0.40 |
| Price to Sales Ratio (Trailing 12 Months) |
0.53 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) |
0.68 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) |
3.56 |
| Pre-Tax Margin (Trailing 12 Months) |
4.91% |
| Net Margin (Trailing 12 Months) |
3.40% |
| Return on Equity (Trailing 12 Months) |
7.42% |
| Return on Assets (Trailing 12 Months) |
3.84% |
| Current Ratio (Most Recent Fiscal Quarter) |
2.43 |
| Quick Ratio (Most Recent Fiscal Quarter) |
1.47 |
| Debt to Common Equity (Most Recent Fiscal Quarter) |
0.48 |
| Inventory Turnover (Trailing 12 Months) |
5.52 |
| Book Value per Share (Most Recent Fiscal Quarter) |
$105.10 |
| Earnings per Share (Most Recent Fiscal Quarter) |
$1.37 |
| Earnings per Share (Most Recent Fiscal Year) |
$8.91 |
| Diluted Earnings per Share (Trailing 12 Months) |
$4.48 |